fb pixel tracking

Precision Medicine

IS HERE

UNLOCKING THE POTENTIAL

The only true predictive pharmacogenomic tool available

PEPID PGx

With Pharmacogenomics

GENES AND ENZYMES IN PEPID PGX

  • CYP1A2
  • CYP2B6
  • CYP2C19
  • CYP2C8
  • CYP2C9/10
  • CYP2D6
  • CYP2E1
  • CYP3A4/5
  • F2
  • MTHFR A1298C
  • MTHFR C677T
  • OATP1B1
  • OPRM1
  • VKORC1
  • APOE
  • ANKK1
  • COMTV158M
  • F5

Moving from

DATA TO DECISIONS

PEPID PGx is backed by the PEPID Drug Database, combining information on over 100,000 drug products, trade names and generics, herbals and nutraceuticals, and more into a single interface that provides all the information clinicians need to immediately optimize patient treatments.

ALTERNATIVE DOSING

Interaction monographs are embedded with in-depth content for relevant drugs and genes.

Reveal comprehensive yet action-oriented monographs that include dosing information by selecting a linked drug or gene.

Delve into monographs, using Quick Links to rapidly access relevant sections.

Use a pre-populated dosing calculator by selecting a linked dose. Choose from standard drug concentrations to determine an alternative dose.

ALTERNATIVE DOSING

Interaction monographs are embedded with in-depth content for relevant drugs and genes.

Reveal comprehensive yet action-oriented monographs that include dosing information by selecting a linked drug or gene.

Delve into monographs, using Quick Links to rapidly access relevant sections.

Use a pre-populated dosing calculator by selecting a linked dose. Choose from standard drug concentrations to determine an alternative dose.

source: ISOGG, Leah Larkin company reports

The practice of precision medicine will impact the entire healthcare process, including the information clinicians need. PEPID PGx is the answer.

learn more about institutional pricing

Simply enter your information to have an Integration Solutions Specialist reach out to you with more information about what special pricing for institutions.

Fill out the form below and we will get back to you shortly.